Dr. Shahzad Anwar Profile

Dr. Shahzad Anwar

Director at Anwar Shahs Trust for CP & Paralysis

SPIE Involvement:

Author

Area of Expertise:

Cerebral Palsy , Development delay , Acupuncture , Epilepsy , Low level laser therapy , Pain management

Websites:

Company Website

Dr. Shahzad is medical doctor also trained in acupuncture, low level laser therapy and prolotherapy. He is working as family physician since 1999. His areas of expertise include neuro-developmental disorders especially Cerebral Palsy (CP), and pain management. He combines his medical background with his experience as complementary and alternative medicine practitioner.
He is conducting research on the treatment of CP and associated neurological disorders. He has many internationally published papers.

Proceedings Article | 18 February 2014 Paper

Comparison of clinical effectiveness of laser acupuncture and amitriptyline in diabetic peripheral neuropathy (DPN): a sham controlled randomized clinical trial

Imran Hassan Khan, Shahzad Anwar, Asif Hanif, Muhammad Ayub, Arsalan Jamil Raja

Proceedings Volume 8932, 893210 (2014) https://doi.org/10.1117/12.2036376

KEYWORDS: Laser therapeutics, Therapeutics, Medicine, Scanning probe lithography, Clinical trials, Visualization, Blood, Statistical analysis, Skin, Tablets

Read Abstract +

Background: Painful neuropathy is a very common complication in diabetic patients. Various treatment strategies like manual therapies, conservative management, drug therapy and exercise have been opted for this problem. Studies have shown clinical effectiveness of laser acupuncture as well. On the other hand, Amitryptaline is also a commonly used treatment for this disease. We aim to compare the efficacy of both treatments. Objective: To assess the effect of laser acupuncture in patients suffering from painful diabetic neuropathy and its comparison with standard of care. Patients and Method: This study was conducted in Diabetic and Endocrine Management Center (DEMC) Lahore General Hospital, Lahore, Pakistan. A randomized control trial (RCT) was opted and a total of 164 patients were chosen using Non-probability purposive sampling technique. Pain was graded by using a patient friendly Visual Analogue Score (VAS), scoring from 0 to 10. Treatment was done involving organized fortnightly follow ups. Data of all patients was recorded on Performa and was entered and analyzed for descriptive statistics in PASW 18 (IBM®. SPSS). Results: A total of 164 subjects were included in the study who were subdivided into three groups labeled as A, B and C for laser therapy treatment, amitryptaline treatment and controls respectively. The mean age of subjects was 51.54±10.46 in Group A, 49.38±10.56 in Group B and 51.70±11.43 in Group C. The difference of mean ages in all study groups was statistically insignificant (p-value= 0.469). The average pain score in patients who received laser therapy was 5.95±0.91 before treatment, whereas after treatment it was 4.31±0.98. The mean pain score in subjects having Amitryptaline before starting the treatment was 6.87±0.71 and after treatment, it was 6.23±0.98. The mean score for daily life activities in subjects who received laser therapy was 9.562.37 before treatment, while after treatment it was 7.56±1.54. The average score for daily life activities in patients having Amitryptaline before starting the treatment was 9.05±1.93 and after treatment, it was 8.11±1.71. Average depression and anxiety score in patients receiving laser therapy was 9.29±2.28 before treatment, whereas after treatment it was found to be 7.42±1.91. Similarly, the mean depression and anxiety score in patients of Amitryptaline group before starting the treatment was 9.38±2.21 and after treatment, it was 8.38±2.14. Conclusion: The mean score in our study reveals that laser therapy shows better outcomes in improvement of pain relief, depression, anxiety and daily life activities compared to amitryptaline in patients of diabetic neuropathy.

Proceedings Article | 10 March 2012 Paper

Aculaser therapy for the treatment of cerebral palsy

Shahzad Anwar, Malik Nazir Khan, Malik Nadeem Khan, Faiza Qazi, Abid Awan, Haseeb Ammad

Proceedings Volume 8211, 82110I (2012) https://doi.org/10.1117/12.903856

KEYWORDS: Neurological disorders, Laser therapeutics, Brain, Epilepsy, Sensors, Neurology, Head, Lead, Blood circulation, Roads

Read Abstract +

A single, open and non comparative study was conducted at Anwar Shah Trust for C.P. & Paralysis in collaboration with the Departments of Neurology and Neurosurgery, Children Hospital Lahore, Pakistan to evaluate the effects of ACULASER THERAPY in childern suffering from Cerebral Palsy (C.P.) and associated Neurological Disorders like epilepsy, cortical blindness, spasticity, hemiplegia, paraplegia, diplegia, quadriplegia, monoplegia, sensoryneural deafness and speech disorders. In all 500 children were treated and the data was gathered during a period of 4 years from December 2006 till December 2010. These children were further classified according to the type of C.P. (spastic, athetoid, mixed) they suffered from and associated Neurological Disorders. This article shows results in C.P. childern who were treated with ACULASER THERAPY for a minimum of 08 weeks and more or had minimum of 15 treatment sessions and more. This article also shows that those childern who were given a break in the treatment for 1 month to 1 year did not show any reversal of the signs and symptoms. Analysis of the data showed that out of 342 children with Spasticity and Stiffness 294 showed marked improvement showing 87% success rate, out of 252 children with Epileptic fits, there was a significant reduction in the intensity, frequency and duration of Epileptic fits in 182 children showing 72% success rate, out of 96 children with Cortical Blindness 60 children showed improvement accounting for 63% efficacy rate, out of 210 children with Hearing Difficulties, 126 showed marked improvement accounting for 60% improvement rate, out of 380 children with Speech Disorders 244 showed improvement reflecting 64 % improvement rate, out of 192 children with Hemiplegia 142 showed improvement in movement, tone and power accounting for 74% improvement rate, out of 152 children with Quadriplegia 104 showed improvement in gross and fine motor functions showing 69% success rate and out of 116 children with Paraplegia of lower limbs 88 showed improvement in weight bearing, standing and movement accounting for 76% improvement rate.

Proceedings Article | 12 February 2008 Paper

Treating cerebral palsy with aculaser therapy

Shahzad Anwar, Malik Nazir Khan, Malik Nadeem Khan, Faiza Qazi, Abid Awan, Irfan Dar

Proceedings Volume 6846, 68460L (2008) https://doi.org/10.1117/12.754282

KEYWORDS: Neurological disorders, Brain, Epilepsy, Laser therapeutics, Sensors, Neurology, Head, Lead, Blood circulation, Roads

Read Abstract +

A single, open and non comparative study was conducted at Anwar Shah Trust for C.P. & Paralysis in collaboration with the Departments of Neurology and Neurosurgery, Children Hospital Lahore, Pakistan to evaluate the effects of ACULASER THERAPY in childern suffering from Cerebral Palsy (C.P.) and associated Neurological Disorders like epilepsy, cortical blindness, spasticity, hemiplegia, paraplegia, diplegia, quadriplegia, monoplegia, sensory-neural deafness and speech disorders. In all 250 childern were treated and the data was gathered during a period of 3 years from December 2003 till December 2006. These children were further classified according to the type of C.P. (spastic, athetoid, mixed) they suffered from and associated Neurological Disorders. This article shows results in C.P. childern who were treated with ACULASER THERAPY for minimum 6 weeks and more or had minimum of 15 treatment sessions and more. This article also shows that those childern who were given a break in the treatment for 1 month to 1 year did not show any reversal of the signs and symptoms. Analysis of the data showed that out of 171 children with Spasticity and Stiffness 147 showed marked improvement showing 87% success rate, out of 126 children with Epileptic fits, there was a significant reduction in the intensity, frequency and duration of Epileptic fits in 91 children showing 72% success rate, out of 48 children with Cortical Blindness 30 children showed improvement accounting for 63% efficacy rate, out of 105 children with Hearing Difficulties, 63 showed marked improvement accounting for 60% improvement rate, out of 190 children with Speech Disorders 122 showed improvement reflecting 64% improvement rate, out of 96 children with Hemiplegia 71 showed improvement in movement, tone and power accounting for 74% improvement rate, out of 76 children with Quadriplegia 52 showed improvement in gross and fine motor functions showing 69% success rate and out of 58 children with Paraplegia of lower limbs 44 showed improvement in weight bearing, standing and movement accounting for 76% improvement rate.

Keywords/Phrases

Search In:

Publication Years